| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.14 | 0.005 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.17 | 0.006 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.006 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.006 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.007 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.14 | 0.007 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.009 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.092 | 0.009 |